Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study

Annals of Internal Medicine

Volumn 134, Issue 6, 2001, Pages 451-458

  Solomon, S D ^a   Glynn, R J ^a   Greaves, S ^a   Ajani, U ^a   Rouleau, J L ^a   Menapace, F ^a   Arnold, J M O ^a   Hennekens, C ^a   Pfeffer, M A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; PLACEBO; RAMIPRIL;

ADULT; AKINESIA; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DYSKINESIA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART AFTERLOAD; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035916954     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-6-200103200-00009     Document Type: Article

References (26)

1. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors
2. Risk stratification and survival after myocardial infarction
3. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
4. Reperfusion of the infarct-related coronary artery limits left ventricular expansion beyond myocardial salvage
5. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994
6. Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: Identification of myocardial stunning and hyperkinesia
7. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial
8. Determinants of prognosis in survivors of myocardial infarction: A prospective clinical angiographic study
9. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
10. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival
11. Time course of left ventricular function and coronary patency after saruplase vs streptokinase in acute myocardial infarction
12. Recovery of left ventricular wall motion in early periods by successful reperfusion following myocardial infarction
13. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction
14. Myocardial 'stunning' in man
15. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
16. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction
17. The creatine kinase curve area and peak creatine kinase after acute myocardial infarction: Usefulness and limitations
18. Estimation of enzymatic infarct size: Direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase
19. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase
20. Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: Comparison with conventional treatment and correlation with infarct size
21. Enzymatic estimation of infarct size during reperfusion
22. Effects of coronary artery reperfusion on relation between creatine kinase-MB release and infarct size estimated by myocardial emission tomography with thallium-201 in man
23. Prognosis of patients with different peak serum creatine kinase levels after first myocardial infarction
24. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
25. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition
26. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril